Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

3VAE

Crystal Structure of M. tuberculosis LD-transpeptidase type 2 with Modified Catalytic Cysteine (C354)

Summary for 3VAE
Entry DOI10.2210/pdb3vae/pdb
DescriptorLD-transpeptidase type 2, DI(HYDROXYETHYL)ETHER (3 entities in total)
Functional Keywordsprotein-peptidoglycan complex, peptidoglycan binding protein
Biological sourceMycobacterium tuberculosis
Cellular locationCell membrane ; Lipid-anchor : O53223
Total number of polymer chains2
Total formula weight62499.32
Authors
Erdemli, S.,Bianchet, M.A.,Gupta, R.,Lamichhane, G.,Amzel, L.M. (deposition date: 2011-12-29, release date: 2012-12-12, Last modification date: 2024-10-30)
Primary citationErdemli, S.B.,Gupta, R.,Bishai, W.R.,Lamichhane, G.,Amzel, L.M.,Bianchet, M.A.
Targeting the Cell Wall of Mycobacterium tuberculosis: Structure and Mechanism of L,D-Transpeptidase 2.
Structure, 20:2103-2115, 2012
Cited by
PubMed Abstract: With multidrug-resistant cases of tuberculosis increasing globally, better antibiotic drugs and novel drug targets are becoming an urgent need. Traditional β-lactam antibiotics that inhibit D,D-transpeptidases are not effective against mycobacteria, in part because mycobacteria rely mostly on L,D-transpeptidases for biosynthesis and maintenance of their peptidoglycan layer. This reliance plays a major role in drug resistance and persistence of Mycobacterium tuberculosis (Mtb) infections. The crystal structure at 1.7 Å resolution of the Mtb L,D-transpeptidase Ldt(Mt2) containing a bound peptidoglycan fragment, reported here, provides information about catalytic site organization as well as substrate recognition by the enzyme. Based on our structural, kinetic, and calorimetric data, we propose a catalytic mechanism for Ldt(Mt2) in which both acyl-acceptor and acyl-donor substrates reach the catalytic site from the same, rather than different, entrances. Together, this information provides vital insights to facilitate development of drugs targeting this validated yet unexploited enzyme.
PubMed: 23103390
DOI: 10.1016/j.str.2012.09.016
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.8 Å)
Structure validation

227561

PDB entries from 2024-11-20

PDB statisticsPDBj update infoContact PDBjnumon